The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa
Abstract
Constitutive overproduction of the pump MexXY-OprM is recognized as a major cause of resistance to aminoglycosides, fluoroquinolones, and zwitterionic cephalosporins in Pseudomonas aeruginosa . In this study, 57 clonally unrelated strains recovered from non-cystic fibrosis patients were analyzed to characterize the mutations resulting in upregulation of the mexXY operon. Forty-four (77.2%) of the strains, classified as agrZ mutants were found to harbor mutations inactivating the local repressor gene ( mexZ ) of the mexXY operon ( n = 33; 57.9%) or introducing amino acid substitutions in its product, MexZ ( n = 11; 19.3%). These sequence variations, which mapped in the dimerization domain, the DNA binding domain, or the rest of the MexZ structure, mostly affected amino acid positions conserved in TetR-like regulators. The 13 remaining MexXY-OprM strains (22.8%) contained intact mexZ genes encoding wild-type MexZ proteins. Eight (14.0%) of these isolates, classified as agrW1 mutants, overexpressed the gene PA5471, which codes for the MexZ antirepressor AmrZ, with 5 strains exhibiting growth defects at 37°C and 44°C, consistent with mutations impairing ribosome activity. Interestingly, one agrW1 mutant appeared to harbor a 7-bp deletion in the coding sequence of the leader peptide, PA5471.1, involved in ribosome-dependent, translational attenuation of PA5471 expression. Finally, DNA sequencing and complementation experiments revealed that 5 (8.8%) strains, classified as agrW2 mutants, harbored single amino acid variations in the sensor histidine kinase of ParRS, a two-component system known to positively control mexXY expression. Collectively, these results demonstrate that clinical strains of P. aeruginosa exploit different regulatory circuitries to mutationally overproduce the MexXY-OprM pump and become multidrug resistant, which accounts for the high prevalence of MexXY-OprM mutants in the clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the resistance of P. aeruginosa to aminoglycosides, fluoroquinolones, and zwitterionic cephalosporins depends on the efflux function of MexXY-OprM.243”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [243]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286
Research works printed but not linked: 52
- 10.1128/CMR.00040-09 · DOI · Paper page
- 10.1128/AAC.43.11.2624 · DOI · Paper page
- 10.1128/AAC.44.9.2242-2246.2000 · DOI · Paper page
- 10.1128/AAC.44.12.3322-3327.2000 · DOI · Paper page
- 10.1128/AAC.43.2.415 · DOI · Paper page
- 10.1128/AAC.43.12.2975 · DOI · Paper page
- 10.1128/AAC.00018-09 · DOI
- 10.1128/AAC.50.4.1347-1351.2006 · DOI
- 10.1128/JB.187.15.5341-5346.2005 · DOI · Paper page
- 10.1111/j.1365-2958.1993.tb00925.x · DOI · Paper page
- 10.1128/AAC.39.11.2567 · DOI
- 10.1128/JB.188.5.1847-1855.2006 · DOI
- 10.1128/JB.00073-09 · DOI
- 10.1099/mic.0.028993-0 · DOI
- 10.1371/journal.pone.0056858 · DOI
- 10.1111/j.1574-6968.2004.tb09732.x · doi:10.1111/j.1574-6968.2004.tb09732.x
- 10.1128/AAC.01212-07 · doi:10.1128/aac.01212-07
- 10.1128/AAC.48.5.1676-1680.2004 · DOI
- 10.1111/j.1469-0691.2011.03530.x · doi:10.1111/j.1469-0691.2011.03530.x
- 10.1128/AAC.47.10.3202-3207.2003 · DOI · Paper page
- 10.1111/j.1469-0691.2004.00991.x · DOI
- 10.1128/AAC.48.5.1797-1802.2004 · DOI · Paper page
- 10.1128/AAC.01252-10 · doi:10.1128/aac.01252-10
- 10.1089/mdr.2011.0019 · doi:10.1089/mdr.2011.0019
- 10.1128/AAC.00846-12 · DOI
- 10.1128/AAC.00704-06 · doi:10.1128/aac.00704-06
- 10.1128/AAC.00253-09 · DOI
- 10.1093/jac/dkt098 · DOI
- 10.1073/pnas.77.12.7347 · DOI · Paper page
- 10.1016/j.jsb.2010.07.012 · DOI
- 10.1038/73324 · DOI
- 10.1107/S0907444904019158 · DOI · Paper page
- 10.1093/bioinformatics/btp033 · DOI · Paper page
- 10.1006/plas.1999.1441 · DOI · Paper page
- 10.1111/j.1574-6968.2005.00008.x · DOI · Paper page
- 10.1073/pnas.0609213104 · DOI · Paper page
- 10.1128/AAC.01388-12 · DOI · Paper page
- 10.1128/AAC.00148-07 · DOI · Paper page
- 10.1046/j.1365-2698.2002.03039.x · doi:10.1046/j.1365-2698.2002.03039.x
- 10.1093/nar/gkr640 · DOI
- 10.3389/fmicb.2012.00408 · DOI · Paper page
- 10.1074/jbc.274.32.22143 · DOI
- 10.1046/j.1365-2958.1999.01562.x · DOI
- 10.1128/AAC.01371-12 · DOI
- 10.1128/JB.01651-09 · DOI · Paper page
- 10.1371/journal.pone.0012669 · DOI
- 10.1073/pnas.0602138103 · DOI · Paper page
- 10.1128/JCM.43.3.1198-1204.2005 · DOI
- 10.1128/AAC.00101-11 · DOI
- 10.1128/AAC.47.6.1887-1894.2003 · DOI
- 10.1128/AAC.43.7.1681 · DOI
- 10.1073/pnas.82.23.8129 · DOI · Paper page
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Self-citationHorcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
Metadata
- Authors
- Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P.
- Affiliations
- Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Régional Universitaire de Besançon, Université de Franche-Comté, Besançon, France
- Laboratoire de Cristallographie et RMN Biologiques, CNRS Université Paris Descartes, Paris, France
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-01
- Volume
- 58
- Issue
- 1
- Pages
- 221-228
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 119
- References
- 1
- Language
- en
- Update notices
- correction (2014-02-19)
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa. https://app.cochat.ai/papers/10.1128/aac.01252-13
- The paper
- Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014). Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01252-13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.